DYAI

Dyadic International, Inc.

 
Common Stock Alternative Reporting
OTCQX U.S. Premier
Verified Company Profile 12/01/2017
Contact Info
  • 140 Intracoastal Pointe Drive
  • Suite 404
  • Jupiter, FL 33477

Business Description


 
Financial Reporting/Disclosure
Reporting Status Alternative Reporting Standard
Deregistered a/o Jun 04, 2009
Audited Financials Audited
Latest Report Sep 30, 2017 Quarterly Report
CIK 0001213809
Fiscal Year End 12/31
OTC Marketplace OTCQX U.S. Premier
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: DE, USA
Year of Inc. 2002
Employees 9 a/o Aug 10, 2017
Company Officers/Contacts
Mark Emalfarb CEO, President
Thomas L. Dubinski CFO
Ping Rawson Director, Financial Reporting
Hiedi Zosiak Executive Assistant
Company Directors
Michael P. Tarnok Chairman
Arindam Bose
Mark Emalfarb
Seth Herbst
Jack Kaye
Company Notes
  • Sponsored for OTCQX by B. Riley & Co., LLC on 03/10/2014
  • Formerly=CCP Worldwide, Inc. until 11-04
Service Providers
OTCQX Advisor
Not Available
Accounting/Auditing Firm
Mayer Hoffman McCann P.C.
1675 N. Military Trail
5th Floor
Boca Raton, FL, 33486
United States

Legal Counsel
Cahill Gordon & Reindel LLP
80 Pine Street
New York, NY, 10005
United States

Investor Relations Firm
Not Available
DYAI Security Details
Share Structure
Market Value1 $54,511,783 a/o Dec 15, 2017
Authorized Shares 100,000,000 a/o Dec 15, 2017
Outstanding Shares 38,936,988 a/o Dec 15, 2017
-Restricted 778,928 a/o Dec 15, 2017
-Unrestricted 38,158,060 a/o Dec 15, 2017
Held at DTC 27,776,929 a/o Dec 15, 2017
Float 20,478,195 a/o Sep 30, 2017
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
Continental Stock Transfer & Trust Company
Shareholders
Shareholders of Record 74 a/o Sep 30, 2017
Short Selling Data
Short Interest 211 (0%)
Nov 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security